Exor Investor Day

PHILIPS HAS SUCCESSFULLY REPOSITIONED ITSELF IN THE HEALTHCARE DOMAIN, AND IS CURRENTLY MANAGING A SET OF CHALLENGES Exor SHARE PRICE (€) SALES (€BN) AND SHARE PRICE EVOLUTION (€) Healthcare (incl. Others) Lighting Entertainment Domestic Appliances -Share Price Respironics recall and operational difficulties 24.8bn 24.2bn 24.5bn 23.3bn 70 10 8% 6% 21.4bn 9% 10% 9% 19.5bn 19.5bn 60 60 10% 17.8bn 18.1bn 6-7% GROWTH1 17.8bn 31% 29% 12% 11% 17.2bn 34% 36% 12% 50 13% 32% 40 40 61% 55% 57% 60% 30 52% 20 89% 88% 88% 87% Exor announces its investment 100% 100% 100% Roy Jakobs is appointed CEO 10 2012 > 2013 2014 2015 2016 2017 2018 2019 >>> 2020 >> 2021 2022 2023E HEALTHCARE ! EXPANSION ✓ VOLCANO PRECISION GUIDED THERAPY Spectranetics Always Reaching Farther Sources: CIQ as of 29 November. Notes: 1) Comparable Sales Growth (CSG) guidance as provided by the company in their 3Q '23 Earnings Call presentation. BioTelemetry 11

View entire presentation